Xeris Biopharma Holdings

ISIN US98422E1038

WKN A3C4ZC

Market cap (in EUR)

1,360 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	1,360 m
EPS, EUR	-0.09
P/B ratio	97.6
P/E ratio	123.8
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	259 m
Net income, EUR	0 m
Profit margin	0.19%

What ETF is Xeris Biopharma Holdings in?

There are 30 ETFs which contain Xeris Biopharma Holdings. All of these ETFs are listed in the table below. The ETF with the largest weighting of Xeris Biopharma Holdings is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares Russell 2000 Swap UCITS ETF USD (Acc)	0.05%	Equity United States Small Cap	51
Xtrackers MSCI World Small Cap UCITS ETF 1D	0.01%	Equity World Small Cap	15
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.06%	Equity United States Small Cap	186
Amundi Russell 2000 UCITS ETF EUR (C)	0.05%	Equity United States Small Cap	617
iShares MSCI World Small Cap UCITS ETF	0.01%	Equity World Small Cap	7,816
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	0.04%	Equity World Health Care Social/Environmental	25
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF EUR Hedged (Acc)	0.05%	Equity United States Small Cap	142
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist	0.05%	Equity United States Small Cap	3
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.01%	Equity World Small Cap	45
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD	0.05%	Equity United States Small Cap	4,123
WisdomTree Russell 2000	0.05%	Equity United States Small Cap	7
Xtrackers MSCI Global Social Fairness Contributors UCITS ETF 1C	0.01%	Equity World Social/Environmental	3
Amundi Russell 2000 UCITS ETF USD	0.05%	Equity United States Small Cap	212
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc)	0.00%	Equity World	8,288
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc	0.02%	Equity United States Small Cap	28
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.01%	Equity World Small Cap	1,723
Xtrackers Russell 2000 UCITS ETF 1C	0.05%	Equity United States Small Cap	1,929
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist)	0.00%	Equity World	238
Xtrackers MSCI Global SDGs UCITS ETF 1C	0.03%	Equity World Social/Environmental	6
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.02%	Equity United States Small Cap	2,425
Xtrackers MSCI World Small Cap UCITS ETF 1C	0.01%	Equity World Small Cap	138
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc	0.05%	Equity United States Small Cap	11
Invesco Nasdaq Biotech UCITS ETF	0.09%	Equity United States Health Care Biotech	497
iShares Russell 2000 Swap UCITS ETF EUR Hedged (Acc)	0.05%	Equity United States Small Cap	79
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.09%	Equity United States Health Care Biotech	71
Invesco Russell 2000 UCITS ETF Acc	0.05%	Equity United States Small Cap	285
iShares Nasdaq US Biotechnology UCITS ETF	0.09%	Equity United States Health Care Biotech	1,035
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD	0.00%	Equity United States Small Cap	893
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc	0.02%	Equity United States Small Cap	41
L&G Pharma Breakthrough UCITS ETF	3.33%	Equity World Health Care Innovation	25

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.

Select your savings amount:

Broker	Rating	Execution fee	Account fee
		0.00 €	0.00 €	View offer*
		0.00 €	0.00 €	View offer*

Detailed comparison of all offers

Source: justETF Research; as of 10/2026. The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable AG. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.

Change your settings